228 related articles for article (PubMed ID: 22471523)
1. Role of carotenoid β-cryptoxanthin in bone homeostasis.
Yamaguchi M
J Biomed Sci; 2012 Apr; 19(1):36. PubMed ID: 22471523
[TBL] [Abstract][Full Text] [Related]
2. Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis.
Yamaguchi M
Yakugaku Zasshi; 2006 Nov; 126(11):1117-37. PubMed ID: 17077614
[TBL] [Abstract][Full Text] [Related]
3. Nutritional factors and bone homeostasis: synergistic effect with zinc and genistein in osteogenesis.
Yamaguchi M
Mol Cell Biochem; 2012 Jul; 366(1-2):201-21. PubMed ID: 22476903
[TBL] [Abstract][Full Text] [Related]
4. beta-Cryptoxanthin stimulates bone formation and inhibits bone resorption in tissue culture in vitro.
Yamaguchi M; Uchiyama S
Mol Cell Biochem; 2004 Mar; 258(1-2):137-44. PubMed ID: 15030178
[TBL] [Abstract][Full Text] [Related]
5. The bone anabolic carotenoid beta-cryptoxanthin enhances transforming growth factor-beta1-induced SMAD activation in MC3T3 preosteoblasts.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2009 Nov; 24(5):671-5. PubMed ID: 19787201
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of beta-cryptoxanthin prevents bone loss in ovariectomized rats.
Uchiyama S; Yamaguchi M
Int J Mol Med; 2006 Jan; 17(1):15-20. PubMed ID: 16328006
[TBL] [Abstract][Full Text] [Related]
7. Daily intake of β-cryptoxanthin prevents bone loss by preferential disturbance of osteoclastic activation in ovariectomized mice.
Ozaki K; Okamoto M; Fukasawa K; Iezaki T; Onishi Y; Yoneda Y; Sugiura M; Hinoi E
J Pharmacol Sci; 2015 Sep; 129(1):72-7. PubMed ID: 26342276
[TBL] [Abstract][Full Text] [Related]
8. Beta-cryptoxanthin stimulates apoptotic cell death and suppresses cell function in osteoclastic cells: change in their related gene expression.
Uchiyama S; Yamaguchi M
J Cell Biochem; 2006 Aug; 98(5):1185-95. PubMed ID: 16514646
[TBL] [Abstract][Full Text] [Related]
9. Combination of beta-cryptoxanthin and zinc has potent effects on apoptotic cell death and suppression of bone resorption-related gene expression in osteoclastic cells.
Yamaguchi M; Uchiyama S
Int J Mol Med; 2008 Aug; 22(2):221-8. PubMed ID: 18636177
[TBL] [Abstract][Full Text] [Related]
10. beta-Cryptoxanthin stimulates cell proliferation and transcriptional activity in osteoblastic MC3T3-E1 cells.
Uchiyama S; Yamaguchi M
Int J Mol Med; 2005 Apr; 15(4):675-81. PubMed ID: 15754031
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of carotenoids and expression of carotenoid biosynthetic genes during maturation in citrus fruit.
Kato M; Ikoma Y; Matsumoto H; Sugiura M; Hyodo H; Yano M
Plant Physiol; 2004 Feb; 134(2):824-37. PubMed ID: 14739348
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of beta-cryptoxanthin on osteoclast-like cell formation in mouse marrow cultures.
Uchiyama S; Yamaguchi M
Biochem Pharmacol; 2004 Apr; 67(7):1297-305. PubMed ID: 15013845
[TBL] [Abstract][Full Text] [Related]
13. The protective effects of β-cryptoxanthin on inflammatory bone resorption in a mouse experimental model of periodontitis.
Matsumoto C; Ashida N; Yokoyama S; Tominari T; Hirata M; Ogawa K; Sugiura M; Yano M; Inada M; Miyaura C
Biosci Biotechnol Biochem; 2013; 77(4):860-2. PubMed ID: 23615426
[TBL] [Abstract][Full Text] [Related]
14. Frequent intake of tropical fruits that are rich in beta-cryptoxanthin is associated with higher plasma beta-cryptoxanthin concentrations in Costa Rican adolescents.
Irwig MS; El-Sohemy A; Baylin A; Rifai N; Campos H
J Nutr; 2002 Oct; 132(10):3161-7. PubMed ID: 12368412
[TBL] [Abstract][Full Text] [Related]
15. Seasonal variation of serum alpha- and beta-cryptoxanthin and 25-OH-vitamin D(3) in women with osteoporosis.
Granado-Lorencio F; Olmedilla-Alonso B; Herrero-Barbudo C; Blanco-Navarro I; Pérez-Sacristán B
Osteoporos Int; 2008 May; 19(5):717-20. PubMed ID: 17882465
[TBL] [Abstract][Full Text] [Related]
16. The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases.
Yamaguchi M
Mol Cell Biochem; 2016 Oct; 421(1-2):193-203. PubMed ID: 27573001
[TBL] [Abstract][Full Text] [Related]
17. Cancer chemoprevention by citrus pulp and juices containing high amounts of β-cryptoxanthin and hesperidin.
Tanaka T; Tanaka T; Tanaka M; Kuno T
J Biomed Biotechnol; 2012; 2012():516981. PubMed ID: 22174562
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic formation of β-citraurin from β-cryptoxanthin and Zeaxanthin by carotenoid cleavage dioxygenase4 in the flavedo of citrus fruit.
Ma G; Zhang L; Matsuta A; Matsutani K; Yamawaki K; Yahata M; Wahyudi A; Motohashi R; Kato M
Plant Physiol; 2013 Oct; 163(2):682-95. PubMed ID: 23966550
[TBL] [Abstract][Full Text] [Related]
19. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of mandarin juice rich in beta-cryptoxanthin and hesperidin on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced pulmonary tumorigenesis in mice.
Kohno H; Taima M; Sumida T; Azuma Y; Ogawa H; Tanaka T
Cancer Lett; 2001 Dec; 174(2):141-50. PubMed ID: 11689289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
